MRK MRK メルク

 MRKのチャート


 MRKの企業情報

symbol MRK
会社名 Merck_Co Inc (MRK メルク)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 事業概要 メルク(Merck_Co. Inc.)はグローバルな医療会社である。同社は処方薬、ワクチン、生物学的療法、動物医薬品を通じて医療ソリューションの提供に従事する。同社は医薬品、動物健康、医療サービス、及びアライアンスという4つの事業区分により構成される。医薬品事業は同社または合弁会社を通じて直接販売されたヒト健康医薬品とワクチン製品を含む。ヒト健康医薬品はヒトの障害の治療のために処方により販売される治療剤・予防剤を含む。同社はヒト健康医薬品医薬品卸売業者・小売業者、病院、政府機関、保健医療機関・薬局給付管理者等の管理医療機関に販売する。ワクチン製品は予防的小児・青年・成人ワクチンを含み、医師の診療所において提供される。  メルクは米国の医薬品大手。医薬品、ワクチン、動物用医薬品、コンシュ―マ―ケア製品の発見、開発、製造、販売を行う。循環器・糖尿病、がん、骨・呼吸器、皮膚科・眼科、感染症、中枢神経、女性疾患の分野でブランドを展開。ペット用ワクチンや予防薬を提供。抗ヒスタミン剤「クラリトン」や便秘薬「ミララックス」などを扱う。  For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of its mission to save and improve lives. It demonstrates its commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals - including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases - as we aspire to be the premier research-intensive biopharmaceutical company in the world.
本社所在地 908 740-4000
代表者氏名 Kenneth C. Frazier
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 908-740-4000
設立年月日 10014
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 69000人
url www.merck.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 16729.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 214680.10000
売上高 売上高(百万ドル) 42294.00000
企業価値(EV) 企業価値(EV)(百万ドル) 230930.10000
当期純利益 当期純利益(百万ドル) 6220.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Merck_Co. Inc. revenues increased 5% to $42.29B. Net income before extraordinary items increased 25% to $6.22B. Revenues reflect Merck Pharmaceutical segment increase of 6% to $37.69B United States segment increase of 5% to $18.21B Europe Middle East and Africa segment increase of 6% to $12.21B. Net income benefited from IPR&D impairment charges decrease of 69% to $152M (expense).

 MRKのテクニカル分析


 MRKのニュース

   Stocks Taking Time to Get Going  2022/04/07 14:15:00 Baystreet Canada
Equities in Toronto traded flat on Thursday, weighed down by uncertainty around the Russia-Ukraine peace talks, although energy stocks gained ahead of the release of the 2022 budget later in the day. The TSX Composite Index fell just short of breakeven, 8.61 points to begin Thursday trading at 21,779.99. The Canadian dollar fell 0.03 cents to 79.55 cents U.S. BlackBerry plans to settle a more than eight-year-old lawsuit claiming it defrauded shareholders by inflating the success and profitability of its long-discontinued BlackBerry 10 smartphones. BlackBerry shares capsized 15 cents, or 1.7%, to $8.53. ATB Capital Markets resumed coverage on Auxly Cannabis Group with an outperform rating and a price target of 40 cents. Auxly shares stayed put at 15 cents. RBC cut the target price on Canfor Corp. to $40.00 from $45.00. Canfor lost 46 cents, or 2%, to $22.33. RBC also cut the target price on Interfor to $45.00 from $50.00. Interfor shares doffed 20 cents to $30.51. The Trudeau Liberals will unveil their 2022 budget around 4 p.m.
   Investors Digest Fed Tightening; Dow Plummets  2022/04/07 14:15:00 Baystreet Canada
Stocks fell again on Thursday, following back-to-back losing sessions, as traders weighed the Federal Reserve’s plans to tighten monetary policy. The Dow Jones Industrials fell 150.52 points to at 34,345.99. The S&P 500 regained 3.07 points to 4,484.22 The NASDAQ Composite picked up 43.21 points to 13,932.03. Utilities, consumer staples and health care companies rose slightly on Thursday as investors continued their search for safe-haven stocks, which included Walmart, Merck and Procter & Gamble. On the tech front, shares of HP Inc surged 13% after Warren Buffett’s Berkshire Hathaway disclosed a stake in the tech hardware maker. Investors also digested initial jobless claims on Thursday, which came in at 166,000 last week, their lowest level since 1968, and signaled the job market remains under pressure. Thursday’s moves come after the Fed released minutes from its March meeting on Wednesday, which showed that officials planned to reduce their trillions in bond holdings with a consensus amount around $95 billion.
   Thursday’s Top Analyst Upgrades and Downgrades: Analog Devices, Eli Lilly, Keurig Dr Pepper, Lululemon Athletica, Merck, Occidental Petroleum, Rivian and More  2022/04/07 12:57:46 24/7 Wall street
Thursday''s top analyst upgrades and downgrades included Analog Devices, Eli Lilly, Fastenal, Global Payments, Keurig Dr Pepper, Lululemon Athletica, Merck, Occidental Petroleum, Rivian Automotive and Stanley Black & Decker.
   The Daily Biotech Pulse: BioXcel''s Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy  2022/04/06 12:02:14 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Iovance Plans to File For Melanoma Therapy Approval In August Following Positive FDA Feedback Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ) said the U.S. Food and Drug Administration on Friday provided a positive feedback regarding its proposed matrix of potency assays for its upcoming biologics license application for lifileucel in metastatic melanoma. Based on this response, Iovance expects to request a pre-BLA meeting in July and to complete a BLA submission for lifileucel by August 2022. The company also announced plans to start a Phase 3 study for lifileucel in combination with Merck & Co., Inc''s (NYSE: MRK ) Keytruda for the treatment of immune checkpoint inhibitor-naïve frontline metastatic melanoma in late 2022. The stock was adding 4.11% to $17.24 in premarket trading. Kintor Announces Positive Phase 3 Results For COVID-19 Treatment Candidate Chinese biopharma Kintor Pharmaceutical Limited (OTC: KNTPF ) announced positive topline results from a Phase 3 study of proxalutamide in outpatients with mild-to-moderate COVID-19, regardless of vaccination status and risk factors.
   Sample Preparation Market Analysis & Forecast 2022-2030 | MDC Research  2022/04/06 11:55:24 Benzinga
Pune, April 06, 2022 (GLOBE NEWSWIRE) -- Sample preparation products like instruments and kits & reagents are basically used for preparing biological and chemical sample from its raw material. The undesirable products or contamination in biological sample can be removed. Sample preparations instruments and kits & reagents are used to make sample that can be used in laboratories, pharmaceutical companies and other research & educational establishments. Sample Preparation Market By Regions The global sample preparation Industry can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of virus clearance, followed by Europe and Asia Pacific. North America will continue to dominate the global sample preparation Industry in the forecast period owing to factors such as highly developed research infrastructure, and presence of private and public funding in the sector of R&D. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan.
   COVID19: Molnupiravir pill administered to 1,000 patients  2022/03/10 16:12:03 Financial Mirror
Almost a thousand patients in Cyprus have been administered Molnupiravir, the antiviral medication for COVID, said Deputy head of pharmaceutical services Elena Panagiotopoulou. Merck anti-Covid oral pill Molnupiravir /Lagevrio 200mg has been administered to 984 patients, and only 7% of them had to be admitted to the hospital. She told the Cyprus News Agency no deaths or any side-effects were reported. Panagiotopoulou said that authorities could not draw safe conclusions regarding the drug’s efficacy. This is only possible if, at the same time this medication was given, a placebo drug was given to an equal number of patients. She explained The post COVID19: Molnupiravir pill administered to 1,000 patients appeared first on Financial Mirror .
   CNBC''s Final Trades: Sherwin-Williams, American Express, Merck, Energy And This Logistics Stock  2022/03/10 12:54:32 Benzinga
On CNBC’s “ Halftime Report Final Trades ,” Brenda Vingiello of Sand Hill Global Advisors said Sherwin-Williams Co’s (NYSE: SHW ) stock has lost 30% year-to-date and the company is “very well positioned.” The news of higher input costs is “already out” and Sherwin-Williams “should have higher volumes as a result of a really healthy market,” she … Full story available on Benzinga.com
   CIS Insulin Market to Witness Huge Growth by Key Players: Eli Lilly, Novo Nordisk, Sanofi Aventis, Merck, Biocon  2022/03/09 14:44:39 OpenPR
The CIS Insulin report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a
   Merck''s Keytruda Shows Improved Metastasis-Free Survival In Melanoma Patients  2022/03/07 15:22:10 Benzinga
Merck & Co Inc (NYSE: MRK ) announced data from Phase 3 KEYNOTE-716 trial of Keytruda (pembrolizumab) as adjuvant treatment for patients with resected stage IIB and IIC melanoma. The trial has met its key secondary endpoint of distant metastasis-free survival (DMFS) at a prespecified interim analysis. In the trial, adjuvant … Full story available on Benzinga.com
   Merck says late-stage melanoma trial for Keytruda met main secondary goal (NYSE:MRK)  2022/03/07 12:02:01 Seeking Alpha
Updating results from its KEYNOTE-716 trial, Merck (MRK) said that its blockbuster anti-PD-1 therapy, Keytruda met the key secondary endpoint of the trial among patients with resected…
   ''Don''t give Molnupiravir to...'': WHO updates guidelines on Merck''s Covid drug. Read here  2022/03/03 15:45:40 Livemint
The WHO has recommended ‘active monitoring’ for drug safety, along with other strategies to mitigate potential harms..WHO says Molnupiravir should only be “provided to non-severe COVID-19 patients” with the highest risk of hospitalisation
   WHO adds Merck antiviral to its COVID treatments, and warns Ukraine has low vaccination rate and surging cases  2022/03/03 15:36:00 MarketWatch
The World Health Organization is updating its guidelines on COVID-19 treatments to include molnupiravir, the antiviral developed by Merck & Co., the first…
   WHO Conditionally Recommends Merck''s COVID-19 Antiviral Pill For High-Risk Patients  2022/03/03 14:58:49 Benzinga
A World Health Organization (WHO) panel has backed the use of Merck & Co Inc''s (NYSE: MRK ) COVID-19 antiviral pill for high-risk patients. The expert panel conditionally recommended molnupiravir for patients with non-severe disease at high risk of hospitalization, such as the immunocompromised, the unvaccinated, older people, and those … Full story available on Benzinga.com
   COVID-19: WHO recommends Merck''s pill under conditions  2022/03/03 12:44:10 The Bobr Times
UPDATE DAY PARIS | The World Health Organization (WHO) on Wednesday recommended the anti-Covid pill from the American Merck (MSD) for patients with COVID-19 who are still mild but who are at high risk of hospitalization, especially the elderly. This treatment, called molnupiravir, is an antiviral that must be administered quickly after the onset of symptoms, […] The post COVID-19: WHO recommends Merck''s pill under conditions first appeared on The Bobr Times .
   Cancer Monoclonal Antibodies Global Market Report 2022  2022/03/03 12:35:00 GlobeNewswire
Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. , Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co. Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. , Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co.

 関連キーワード  (医薬品 米国株 MRK メルク MRK )

 twitter  (公式ツイッターやCEOツイッターなど)

MRK動画